To interrogate this hypothesis, we characterized activation of caspase-4 in liver tissue from patients with stable compensated and acutely decompensated cirrhosis, and explored the activation of caspase-11 and GSDMD in a mouse model of liver fibrosis with multi-organ injury. Here, CASP4 is linked to Hepatic fibrosis.